Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats.

Rousseau J, Barth RF, Moeschberger ML, Elleaume H.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):530-6. doi: 10.1016/j.ijrobp.2008.09.018.

2.

The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.

Tanriover N, Ulu MO, Sanus GZ, Bilir A, Canbeyli R, Oz B, Akar Z, Kuday C.

Neurol Res. 2008 Jun;30(5):511-7.

PMID:
18953742
3.

Rethinking brain tumors: the fourth Mouse Models of Human Cancers Consortium nervous system tumors workshop.

Reilly KM, Rubin JB, Gilbertson RJ, Garbow JR, Roussel MF, Gutmann DH.

Cancer Res. 2008 Jul 15;68(14):5508-11. doi: 10.1158/0008-5472.CAN-08-0703. No abstract available.

4.

Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.

Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C, Barbier EL.

NMR Biomed. 2008 Nov;21(10):1043-56. doi: 10.1002/nbm.1278.

PMID:
18615861
5.

Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.

Black KL, Yin D, Konda BM, Wang X, Hu J, Ko MK, Bayan JA, Sacapano MR, Espinoza AJ, Ong JM, Irvin D, Shu Y.

Brain Res. 2008 Aug 28;1227:198-206. doi: 10.1016/j.brainres.2008.06.046. Epub 2008 Jun 21.

6.

Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods.

Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X, Wen L, Yang X.

In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):280-9. doi: 10.1007/s11626-008-9115-z. Epub 2008 Jul 2.

PMID:
18594936
7.

Efficacy of suicide gene therapy in hypoxic rat 9L glioma cells.

Kumar S, Brown SL, Kolozsvary A, Freytag SO, Kim JH.

J Neurooncol. 2008 Oct;90(1):19-24. doi: 10.1007/s11060-008-9635-0. Epub 2008 Jul 2.

8.

Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.

Pulkkinen M, Pikkarainen J, Wirth T, Tarvainen T, Haapa-aho V, Korhonen H, Seppälä J, Järvinen K.

Eur J Pharm Biopharm. 2008 Sep;70(1):66-74. doi: 10.1016/j.ejpb.2008.04.018. Epub 2008 Apr 29.

PMID:
18555675
9.

MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105.

Zhang D, Feng XY, Henning TD, Wen L, Lu WY, Pan H, Wu X, Zou LG.

Eur J Radiol. 2009 Apr;70(1):180-9. doi: 10.1016/j.ejrad.2008.04.022. Epub 2008 Jun 9.

PMID:
18541399
10.

Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.

Solly F, Fish R, Simard B, Bolle N, Kruithof E, Polack B, Pernod G.

Cancer Gene Ther. 2008 Oct;15(10):685-92. doi: 10.1038/cgt.2008.36. Epub 2008 Jun 6.

PMID:
18535615
11.

Dibromoacetonitrile-induced protein oxidation and inhibition of proteasomal activity in rat glioma cells.

Ahmed AE, Jacob S, Nagy AA, Abdel-Naim AB.

Toxicol Lett. 2008 Jun 10;179(1):29-33. doi: 10.1016/j.toxlet.2008.03.017. Epub 2008 Apr 8.

PMID:
18485629
12.

Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.

Zhao S, Zhang X, Zhang J, Zhang J, Zou H, Liu Y, Dong X, Sun X.

J Chemother. 2008 Apr;20(2):253-62.

PMID:
18467254
13.

Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.

Sheehan J, Ionescu A, Pouratian N, Hamilton DK, Schlesinger D, Oskouian RJ Jr, Sansur C.

J Neurosurg. 2008 May;108(5):972-8. doi: 10.3171/JNS/2008/108/5/0972.

PMID:
18447715
14.

In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma.

Valable S, Barbier EL, Bernaudin M, Roussel S, Segebarth C, Petit E, Rémy C.

Neuroimage. 2008 Apr 1;40(2):973-83.

15.

FDG-PET imaging for the evaluation of antiglioma agents in a rat model.

Assadian S, Aliaga A, Del Maestro RF, Evans AC, Bedell BJ.

Neuro Oncol. 2008 Jun;10(3):292-9. doi: 10.1215/15228517-2008-014. Epub 2008 Apr 22.

16.

Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme.

Zagorac D, Jakovcevic D, Gebremedhin D, Harder DR.

J Cereb Blood Flow Metab. 2008 Aug;28(8):1431-9. doi: 10.1038/jcbfm.2008.31. Epub 2008 Apr 16.

17.

A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line.

Bryant MJ, Chuah TL, Luff J, Lavin MF, Walker DG.

J Clin Neurosci. 2008 May;15(5):545-51. doi: 10.1016/j.jocn.2007.04.022.

PMID:
18378459
18.

Intratumoral vs systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model.

Mannino S, Molinari A, Sabatino G, Ciafrè SA, Colone M, Maira G, Anile C, Arancia G, Mangiola A.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):227-31.

PMID:
18336750
19.

Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.

Bansal A, Shuyan W, Hara T, Harris RA, Degrado TR.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1192-203. doi: 10.1007/s00259-008-0736-y. Epub 2008 Feb 9.

20.

Irradiation of intracerebral 9L gliosarcoma by a single array of microplanar x-ray beams from a synchrotron: balance between curing and sparing.

Regnard P, Le Duc G, Bräuer-Krisch E, Troprès I, Siegbahn EA, Kusak A, Clair C, Bernard H, Dallery D, Laissue JA, Bravin A.

Phys Med Biol. 2008 Feb 21;53(4):861-78. doi: 10.1088/0031-9155/53/4/003. Epub 2008 Jan 15.

PMID:
18263945

Supplemental Content

Support Center